Market Place
Sourcing Support
Novo Holdings Completes Acquisition of Catalent
18 Dec 2024 //
BUSINESSWIRE
Regulatory conditions on Novo $16.5 billion Catalent deal fulfilled
16 Dec 2024 //
PRESS RELEASE
Novo holding Clears Catalent Buy & 3 Novo Nordisk Sites Acquisitions
14 Dec 2024 //
PRESS RELEASE
Novo Holdings` $16.5 bln Catalent buy wins EU antitrust approval
09 Dec 2024 //
PRESS RELEASE
Novo Holdings set to win EU nod for $16.5 bln Catalent deal
23 Nov 2024 //
REUTERS
EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 bln deal
13 Nov 2024 //
REUTERS
Catalent Misses Q1 Revenue Estimates Before Novo Holdings Deal
05 Nov 2024 //
REUTERS
Catalent Reports First Quarter Fiscal 2025 Results
05 Nov 2024 //
BUSINESSWIRE
IsomAb Announces Strategic Collaboration with Catalent
28 Oct 2024 //
PRESS RELEASE
Roche CEO critiques Novo`s proposed Catalent buyout
23 Oct 2024 //
FIERCE PHARMA
Roche CEO Says Closing Novo-Catalent Deal Would Be Wrong Decision
23 Oct 2024 //
ENDPTS
Roche comes out against takeover of manufacturer Catalent
22 Oct 2024 //
REUTERS
Catalent Issues Open Letter On Pending Acquisition By Novo Holdings
21 Oct 2024 //
BUSINESSWIRE
Consumer groups ask FTC to block Novo Holdings-Catalent deal
17 Oct 2024 //
REUTERS
Catalent to sell New Jersey facility
15 Oct 2024 //
REUTERS
Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility
14 Oct 2024 //
PRESS RELEASE
Pressure Mounts on Novo’s $16.5B Catalent Buy Amid FTC Review
11 Oct 2024 //
BIOSPACE
Pace Life Acquires Analytical Services Laboratory from Catalent
27 Sep 2024 //
CONTRACT PHARMA
Pace® Acquires Catalent’s Lab To Expand Analytical Services
26 Sep 2024 //
PRESS RELEASE
Catalent delays filing of annual report
30 Aug 2024 //
REUTERS
Catalent beats revenue estimates ahead of deal close with Novo Holdings
29 Aug 2024 //
REUTERS
Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results
29 Aug 2024 //
BUSINESSWIRE
De Motu Cordis Expands DPI Partnership with Catalent
24 Jul 2024 //
CONTRACT PHARMA
Former FTC director weighs in on Novo`s $16.5B deal with Catalent
19 Jul 2024 //
FIERCE PHARMA
Catalent Completes 25 Million Expansion Of Clinical Supply Facility
16 Jul 2024 //
PRESS RELEASE
Catalent Expands Clinical Supply Facility In Germany With $25M Investment
16 Jul 2024 //
PRESS RELEASE
Catalent stockholders approve buyout by Novo Holdings
30 May 2024 //
REUTERS
Catalent Stockholders Approve Transaction with Novo Holdings
29 May 2024 //
PRESS RELEASE
Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
17 May 2024 //
PRESS RELEASE
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
08 May 2024 //
BUSINESSWIRE
FTC to review Novo Holdings` Catalent buyout for another month
04 May 2024 //
FIERCE PHARMA
Novo Nordisk parent refiles US application on Catalent deal
09 Apr 2024 //
REUTERS
FTC to review Novo Holdings` Catalent buyout for 30 more days
05 Apr 2024 //
FIERCE PHARMA
Catalent cuts 130 workers in Indiana; Merck KGaA to build in South Korea
21 Mar 2024 //
ENDPTS
Catalent Publishes Fifth Annual Corporate Responsibility Report
07 Mar 2024 //
BUSINESSWIRE
Competitor manufacturers could benefit from Novo’s acquisition of Catalent
20 Feb 2024 //
ENDPTS
Catalent reorg leaves 300 without jobs as CDMO awaits buyout
16 Feb 2024 //
FIERCE PHARMA
Catalent`s sales continue to be plagued by low COVID demand
09 Feb 2024 //
FIERCE PHARMA
Astrazeneca says Catalent deal shows need for in-house capacity
08 Feb 2024 //
REUTERS
Catalent’s Indiana site closes out three Form 483s in past two years
08 Feb 2024 //
ENDPTS
Lilly CEO raises concerns about Novo-Catalent buy
07 Feb 2024 //
ENDPTS
Catalent`s Indiana filling plant in hot water with the FDA again
07 Feb 2024 //
FIERCE PHARMA
US FDA finds control lapses at Catalent plant being sold to Novo
06 Feb 2024 //
REUTERS
Novo Nordisk`s parent to buy Catalent for $16.5 bln to boost Wegovy supply
06 Feb 2024 //
REUTERS
Thermo Fisher mulls Irish site exit Catalent assists with Wegovy manufacturing
01 Feb 2024 //
ENDPTS
Catalent Announces Second Quarter Fiscal Year 2024 Earnings Conference Webcast
26 Jan 2024 //
BUSINESSWIRE
Catalent Commits to Reducing Greenhouse Gas Emissions by 2030
25 Jan 2024 //
BUSINESSWIRE
JPM24: Catalent poised to pounce on GLP-1 opportunity, CEO says
11 Jan 2024 //
FIERCE PHARMA
Catalent, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 Jan 2024 //
BUSINESSWIRE
Catalent Announces Closing of Incremental Term Loans
19 Dec 2023 //
BUSINESSWIRE
Catalent Regains Compliance with NYSE Continued Listing Standards
15 Dec 2023 //
BUSINESSWIRE
Catalent details revenue downturn
11 Dec 2023 //
ENDPTS
Catalent sees weight-loss drugs boom driving bookings until FY 2026
15 Nov 2023 //
REUTERS
Catalent pins hopes on GLP-1s, Sarepta`s Elevidys
15 Nov 2023 //
FIERCE PHARMA
Catalent, Inc. Reports Preliminary First Quarter Fiscal 2024 Results
15 Nov 2023 //
BUSINESSWIRE
Catalent delays quarterly filing with SEC on $700 mln impairment charge
14 Nov 2023 //
REUTERS
Catalent cites impairment charge for quarterly earnings delay
14 Nov 2023 //
FIERCE PHARMA
Catalent Announces First Quarter Fiscal Year 2024 Earnings Conference Webcast
31 Oct 2023 //
BUSINESSWIRE
Catalent`s stock down after Sarepta’s PhIII Duchenne study misses endpoint
31 Oct 2023 //
ENDPTS
Melt Pharmaceuticals Announces License Agreement with Catalent
26 Sep 2023 //
BUSINESSWIRE
